// App-Quantinova.ai

Su1312 : A Validated Web-Based Patient Communication Tool to Display Individualized Crohn's Disease Predicted Outcomes Based on Clinical, Serologic and Genetic Variables

Researchers

Presenter

  • Henry Horton

Principal Investigators

  • Lori S. Siegel

  • Raquel Milgrom

  • Parambir S. Dulai

  • Mark S. Silverberg

  • Marla Dubinsky

  • Dermot P. McGovern

  • Kimberly D. Thompson

  • Todd MacKenzie

  • Sabrina K. Stewart

  • Philip Rice

  • Joanne M. Stempak

  • Seper Dezfoli

  • Alexander N. Levy

  • Michael D. Baek

Medical Centers

  • Zane Cohen Centre, IBD Research Unit, Mount Sinai Hospital, Toronto, Ontario, Canada

  • Siegel Environmental Dynamics, Hanover, NH

  • Pediatrics, Geisel School of Medicine at Dartmouth, Hanover, NH

  • the F.Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars Sinai Medical Center, Los Angeles, California, United States

  • Dartmouth-Hitchcock Inflammatory Bowel Disease Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

  • Climate Interactive, Hartland, VT

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Anal fistula

  • Crohn's disease

Biomarkers

  • Nucleotide-binding oligomerization domain-containing protein 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved